Key result
Axillary cannulation reduces in-hospital mortality ~30% compared with femoral cannulation.
Why the study?
The optimal arterial cannulation strategy for acute type A aortic dissection (ATAAD) remains controversial, necessitating comparison of clinical outcomes across common cannulation strategies within a unified analytical framework.
Does axillary/subclavian artery cannulation reduce in-hospital mortality and complications compared to other arterial cannulation strategies in patients with acute type A aortic dissection?
Meta-Analysis (n=24,118)
Does axillary/subclavian artery cannulation reduce in-hospital mortality and complications compared to other arterial cannulation strategies in patients with acute type A aortic dissection?
Answers are grounded in this paper and cite their sources.
In acute type A aortic dissection repair, axillary/subclavian artery cannulation provides superior in-hospital survival and stroke protection compared to femoral artery cannulation, while avoiding combined axillary-femoral cannulation reduces renal complications and operative time.
Background: Recently, the optimal arterial cannulation strategy for acute type A aortic dissection (ATAAD) remains controversial. This study aims to perform a network meta-analysis comparing the clinical outcomes of common cannulation strategies, such as axillary/subclavian artery (AxA), femoral artery (FA), aortic artery (AA), innominate artery (IA), carotid artery (CA), and combined axillary and femoral arteries (AxF), within a unified analytical framework. Methods: A systematic search of PubMed, Scopus, ScienceDirect, and Cochrane databases was conducted up to February 2026 to identify comparative studies reporting clinical outcomes for various arterial cannulation strategies in ATAAD. Outcomes assessed included in-hospital mortality, 30-day mortality, stroke, renal failure requiring hemodialysis or continuous renal replacement therapy (CRRT), and operation time. All statistical analysis is performed using the R package netmeta. Results: Fifty-four studies and 24,118 patients were included (AxA, n=10,036; FA, n=7,462; AA, n= 3,546; AxF, n=2,286; IA, n=612; CA, n=114). Compared with FA, AxA significantly reduced in-hospital mortality (RR 0.70 [0.54–0.91]), with no significant difference in 30-day mortality. AxA also lowered stroke risk versus FA (RR 0.78, [0.66–0.91]) and AA (RR 0.76 [0.62–0.94]). Furthermore, AxA reduced the need for CRRT compared with AxF (RR 0.81, [0.66–1.00]). Conversely, AA shortened operative time compared to AxF (MD –56.79 minutes [–100.99 to –12.59]) and AxA (MD –34.75 minutes [–67.35 to –2.15]). Conclusion: AxA offer superior survival and neurologic protection in ATAAD. Avoidance of AxF may reduce renal complications and shorten operative time. Prospective trials are needed to validate these findings and refine patient-specific cannulation strategies.
No takes yet. Share an insight, caveat, or question.
Patongai et al. (2026) conducted a meta-analysis in Acute type A aortic dissection (ATAAD) (n=24,118). Axillary/subclavian artery (AxA) cannulation vs. Femoral artery (FA), aortic artery (AA), innominate artery (IA), carotid artery (CA), and combined axillary and femoral arteries (AxF) cannulation was evaluated on In-hospital mortality (RR 0.70, 95% CI 0.54-0.91). Axillary/subclavian artery cannulation reduced in-hospital mortality and stroke risk compared with femoral artery cannulation.
Synapse has enriched 10 related papers. Consider them for comparative context: